Inhibition of dipeptidyl peptidase 4 (DPP4) activates immune cells chemotaxis in hepatocellular carcinoma
作者： Kristina Kovacovicova , Manlio Vinciguerra
DOI: 10.1016/J.ONSIG.2019.08.001
关键词: Immune system 、 Cancer research 、 Chemotaxis 、 Biology 、 Dipeptidyl peptidase-4 、 Hepatocellular carcinoma
摘要: Abstract A recent work by Nishina et al. provides new evidence that DPP4 inhibitors exert antitumor effects against hepatocellular carcinoma (HCC) orchestrating immune responses.
sci-hub.se 参考文章(20)
Pamela A Havre, Masako Abe, Yasuyo Urasaki, Kei Ohnuma, Chikao Morimoto, Nam H Dang, The role of CD26/dipeptidyl peptidase IV in cancer Frontiers in Bioscience. ,vol. 13, pp. 1634- 1645 ,(2008) , 10.2741/2787
Nathalie C. Leite, Gil F. Salles, Antonio L. E. Araujo, Cristiane A. Villela-Nogueira, Claudia R. L. Cardoso, Prevalence and associated factors of non-alcoholic fatty liver disease in patients with type-2 diabetes mellitus. Liver International. ,vol. 29, pp. 113- 119 ,(2009) , 10.1111/J.1478-3231.2008.01718.X
M. D. Gorrell, V. Gysbers, G. W. McCaughan, CD26: a multifunctional integral membrane and secreted protein of activated lymphocytes. Scandinavian Journal of Immunology. ,vol. 54, pp. 249- 264 ,(2001) , 10.1046/J.1365-3083.2001.00984.X
Mario GONZALEZ-GRONOW, Hernan E. GRENETT, Michael R. WEBER, Govind GAWDI, Salvatore V. PIZZO, Interaction of plasminogen with dipeptidyl peptidase IV initiates a signal transduction mechanism which regulates expression of matrix metalloproteinase-9 by prostate cancer cells. Biochemical Journal. ,vol. 355, pp. 397- 407 ,(2001) , 10.1042/0264-6021:3550397
Armanda Casrouge, Jérémie Decalf, Mina Ahloulay, Cyril Lababidi, Hala Mansour, Anaïs Vallet-Pichard, Vincent Mallet, Estelle Mottez, James Mapes, Arnaud Fontanet, Stanislas Pol, Matthew L. Albert, Evidence for an antagonist form of the chemokine CXCL10 in patients chronically infected with HCV Journal of Clinical Investigation. ,vol. 121, pp. 308- 317 ,(2011) , 10.1172/JCI40594
C. F. Deacon, Dipeptidyl peptidase‐4 inhibitors in the treatment of type 2 diabetes: a comparative review Diabetes, Obesity and Metabolism. ,vol. 13, pp. 7- 18 ,(2011) , 10.1111/J.1463-1326.2010.01306.X
Rosa Barreira da Silva, Melissa E Laird, Nader Yatim, Laurence Fiette, Molly A Ingersoll, Matthew L Albert, Dipeptidylpeptidase 4 inhibition enhances lymphocyte trafficking, improving both naturally occurring tumor immunity and immunotherapy Nature Immunology. ,vol. 16, pp. 850- 858 ,(2015) , 10.1038/NI.3201
Erin E. Mulvihill, Daniel J. Drucker, Pharmacology, Physiology, and Mechanisms of Action of Dipeptidyl Peptidase-4 Inhibitors Endocrine Reviews. ,vol. 35, pp. 992- 1019 ,(2014) , 10.1210/ER.2014-1035
Minoru Itou, Takumi Kawaguchi, Eitaro Taniguchi, Michio Sata, Dipeptidyl peptidase-4: A key player in chronic liver disease World Journal of Gastroenterology. ,vol. 19, pp. 2298- 2306 ,(2013) , 10.3748/WJG.V19.I15.2298
Christopher D. Byrne, Giovanni Targher, NAFLD: A multisystem disease Journal of Hepatology. ,vol. 62, ,(2015) , 10.1016/J.JHEP.2014.12.012